Bill & Melinda Gates Medical Research Institute

The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns and for which the required development investment by traditional biopharmaceutical organizations is lacking. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs).

68%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

100%

Examples:

  • The article does not explicitly state any biases or conflicts of interest in its research and development activities.

Conflicts of Interest

50%

Examples:

  • The article does not disclose any potential conflicts of interest related to its funding sources or partnerships with pharmaceutical companies.
  • The article does not mention any financial interests or incentives that may influence the development and use of M72/AS01E as a TB vaccine candidate.

Contradictions

50%

Examples:

  • The article contradicts itself by claiming that M72/AS01E could be the first new TB vaccine in over a century if proven effective, while also admitting that there are ongoing research efforts to develop new and improved vaccines against TB.
  • The article contradicts itself by claiming that M72/AS01E could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, while also admitting that there are already existing vaccines available (such as BCG) that provide some protection against pulmonary TB.

Deceptions

50%

Examples:

  • The article does not provide sufficient evidence or data to support its claims that M72/AS01E could be the first new TB vaccine in over a century, or that it could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults.
  • The article uses vague and misleading language to present its research findings and implications.

Recent Articles

  • New TB Vaccine Trial Brings Hope to End the Pandemic in South Africa and Beyond

    New TB Vaccine Trial Brings Hope to End the Pandemic in South Africa and Beyond

    Broke On: Tuesday, 19 March 2024 The Gates MRI has initiated a Phase 3 clinical trial to evaluate the effectiveness of the M72/AS01E vaccine candidate in protecting adolescents and adults from pulmonary tuberculosis. If successful, it could be the first new TB vaccine in over a century. The trial is significant as it brings hope for ending TB through prevention and early diagnosis.